![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/convergent-therapeutics-appoints-scott-myers-as-chairman-of-its-board-of-directors-302077694.html
https://www.prnewswire.com/news-releases/convergent-therapeutics-expands-leadership-team-with-the-appointments-of-neil-bander-md-as-chief-scientific-officer-eric-m-sullivan-as-chief-financial-officer-and-dimitris-voliotis-md-as-senior-vice-president-of-clinical-de-301918137.html
https://www.prnewswire.com/news-releases/convergent-therapeutics-to-announce-clinical-trial-updates-on-its-lead-candidate-at-the-american-society-of-clinical-oncology-asco-annual-meeting-2023-301834030.html
https://www.biopharmadive.com/news/convergent-radiopharmaceutical-series-a-funding-cancer/649545/
https://www.fiercebiotech.com/biotech/radiopharmaceutical-company-convergent-closes-series-tune-90m
https://www.prnewswire.com/news-releases/convergent-therapeutics-announces-90-million-series-a-financing-to-advance-the-clinical-development-of-radiopharmaceuticals-for-the-treatment-of-prostate-cancer-and-other-solid-tumors-301813685.html